Pharmacokinetics of indinavir in HIV-infected children

被引：0
|
作者：
Burger, DM
Hugen, PWH
de Groot, R
机构：
[1] Univ Nijmegen Hosp, Dept Clin Pharm, NL-6500 HB Nijmegen, Netherlands
[2] Sophia Childrens Hosp, Dept Pediat Dis, NL-3015 GJ Rotterdam, Netherlands
来源：
AIDS | 1998年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P304
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetic Study of the Variability of Indinavir Drug Levels when Boosted with Ritonavir in HIV-Infected Children
    Curras, Veronica
    Hoecht, Christian
    Mangano, Andrea
    Niselman, Viviana
    Marino Hernandez, Eduardo
    Ceceres Guido, Paulo
    Mecikovsky, Debora
    Bellusci, Carolina
    Bologna, Rosa
    Sen, Luisa
    Rubio, Modesto C.
    Bramuglia, Guillermo F.
    PHARMACOLOGY, 2009, 83 (01) : 59 - 66
  • [22] Pharmacokinetics of antiretrovirals administered to HIV-infected children via gastrostomy tube
    King, JR
    Yogev, R
    Aldrovandi, G
    Chadwick, E
    Acosta, EP
    HIV CLINICAL TRIALS, 2004, 5 (05): : 288 - 293
  • [23] Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents
    Kiser, Jennifer J.
    Rutstein, Richard M.
    Samson, Pearl
    Graham, Bobbie
    Aldrovandi, Grace
    Mofenson, Lynne M.
    Smith, Elizabeth
    Schnittman, Steven
    Fenton, Terry
    Brundage, Richard C.
    Fletcher, Courtney V.
    AIDS, 2011, 25 (12) : 1489 - 1496
  • [24] Pharmacometric Characterization of Efavirenz Developmental Pharmacokinetics and Pharmacogenetics in HIV-Infected Children
    Salem, Ahmed Hamed
    Fletcher, Courtney V.
    Brundage, Richard C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (01) : 136 - 143
  • [25] Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children
    Mukherjee, A.
    Velpandian, T.
    Singla, M.
    Kanhiya, K.
    Kabra, S. K.
    Lodha, R.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (05) : 666 - 672
  • [26] Sertraline Pharmacokinetics in HIV-Infected and Uninfected Children, Adolescents, and Young Adults
    Hanan, Nathan John
    Paul, Mary Elizabeth
    Huo, Yanling
    Kapetanovic, Suad
    Smith, Elizabeth
    Siberry, George
    Brouwers, Pim
    Graham, Bobbie
    Johnston, Benjamin
    Capparelli, Edmund V.
    Best, Brookie M.
    FRONTIERS IN PEDIATRICS, 2019, 7
  • [27] Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load
    Arnaiz, JA
    Mallolas, J
    Podzamczer, D
    Gerstoft, J
    Lundgren, JD
    Cahn, P
    Fätkenheuer, G
    D'Arminio-Monforte, A
    Casiró, A
    Reiss, P
    Burger, DM
    Stek, M
    Gatell, JM
    AIDS, 2003, 17 (06) : 831 - 840
  • [28] Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women
    Kosel, BW
    Beckerman, KP
    Hayashi, S
    Homma, M
    Aweeka, FT
    AIDS, 2003, 17 (08) : 1195 - 1199
  • [29] Therapeutic drug monitoring of indinavir in HIV-Infected patients undergoing HAART
    Langmann, R
    Zilly, M
    Weissbrich, B
    Desch, S
    Väth, T
    Klinker, H
    INFECTION, 2002, 30 (01) : 13 - 16
  • [30] Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients
    Dieleman, JP
    Gyssens, IC
    van der Ende, ME
    de Marie, S
    Burger, DM
    AIDS, 1999, 13 (04) : 473 - 478
12345